Intercaudate nucleus ratio as a linear measure of brain atrophy in multiple sclerosis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 12552053.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intercaudate nucleus ratio (ICR) is a linear measure of brain atrophy that does not require software application and is independent of image acquisition techniques. The authors examined the relationship between ICR and disability in 190 patients with MS. The results show that ICR correlates with Expanded Disability Status Scale score (r = 0.67; p = 0.0001) and disease duration (r = 0.32; p < 0.01). Intercaudate ratio appears to be a reliable and reproducible linear measure of brain atrophy and correlates with disability and disease duration in MS.
Medical subject headings
- Atrophy
- Brain
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Relapsing-Remitting